Brigade Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-12,765,651
| Closed | -$11M | – | 64 |
|
|
2019
Q4 | $11M | Buy |
12,765,651
+497,026
| +4% | +$382K | 0.82% | 23 |
|
|
2019
Q3 | $6.88M | Hold |
12,268,625
| – | – | 0.37% | 31 |
|
|
2019
Q2 | $6.38M | Hold |
12,268,625
| – | – | 0.32% | 36 |
|
|
2019
Q1 | $5.52M | Hold |
12,268,625
| – | – | 0.34% | 39 |
|
|
2018
Q4 | $5.89M | Hold |
12,268,625
| – | – | 0.2% | 49 |
|
|
2018
Q3 | $6.5M | Hold |
12,268,625
| – | – | 0.38% | 43 |
|
|
2018
Q2 | $6.13M | Hold |
12,268,625
| – | – | 0.41% | 37 |
|
|
2018
Q1 | $5.18M | Hold |
12,268,625
| – | – | 0.24% | 44 |
|
|
2017
Q4 | $4.66M | Hold |
12,268,625
| – | – | 0.26% | 50 |
|
|
2017
Q3 | $4.42M | Hold |
12,268,625
| – | – | 0.36% | 45 |
|
|
2017
Q2 | $4.66M | Hold |
12,268,625
| – | – | 0.39% | 39 |
|
|
2017
Q1 | $5.52M | Sell |
12,268,625
-190
| -0% | -$83 | 0.72% | 37 |
|
|
2016
Q4 | $4.66M | Buy |
12,268,815
+52,984
| +0.4% | +$17.9K | 0.19% | 39 |
|
|
2016
Q3 | $3.3M | Buy |
+12,215,831
| New | +$3.09M | 0.17% | 40 |
|
Brigade Capital Management's GCVRZ Position: Q1 2020 in Review
Brigade Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 12,765,651 shares — an estimated $11M sold.
Brigade Capital Management first reported a position in GCVRZ in Q3 2016 and held it in 14 quarters. The position peaked at $11M in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Brigade Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Brigade Capital Management sold 12,765,651 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $11M.
- Brigade Capital Management first reported a position in Sanofi Contingent Value Rights in Q3 2016 and held it in 14 quarters.
- Brigade Capital Management's Sanofi Contingent Value Rights position peaked at $11M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Brigade Capital Management's 13F filing for Q1 2020, filed 15 May 2020.